| Richard E Paulus, MD | |
|
613 23rd St, Ste 230, Ashland, KY 41101-2876 | |
| (606) 324-4745 | |
| (606) 326-0165 |
| Full Name | Richard E Paulus |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 613 23rd St, Ashland, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700875986 | NPI | - | NPPES |
| 64002470 | Medicaid | KY | |
| 000000049963 | Other | KY | ANTHEM BLUECROSS & BLUESH |
| 000733000 | Other | WV | MT STATE BCBS |
| 0086372000 | Medicaid | WV | |
| 0906416 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 29247 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Richard E Paulus, MD Po Box 2380, Ashland, KY 41105-2380 Ph: (606) 324-4745 | Richard E Paulus, MD 613 23rd St, Ste 230, Ashland, KY 41101-2876 Ph: (606) 324-4745 |
News Archive
A study of more than 80,000 women with heart disease from 2003 to 2012 reveals that the prevalence of women with heart disease delivering babies increased by 24 percent over that 10-year period.
Cardiovascular disease specialists at Florida Hospital Pepin Heart Institute and Dr. Kiran C. Patel Research Institute affiliated with the University of South Florida announced they have enrolled their first patients into a clinical trial testing a novel gene therapy for the treatment of heart failure after ischemic injury. The therapy may promote the regeneration of heart tissue by encouraging the body to deploy more stem cells to the injury site.
According to a latest survey from the National Institute of Mental Health (NIMH), the rates of suicides is two times higher for black children aged between 5 and 12 years compared to white children of the same age. The results of the study are published yesterday (21st May 2018) in the latest issue of the journal JAMA Pediatrics.
RegeneRx Biopharmaceuticals, Inc. announced that it has received Orphan Drug designation from U.S. FDA's Office of Orphan Products Development for its drug candidate, Thymosin beta 4 (Tβ4), for the treatment of Neurotrophic Keratopathy, a serious degenerative disease of the corneal epithelium (the outside layer of the eye).
› Verified 4 days ago
Padma Venkatraman, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 101 Ashland Dr, Ashland, KY 41101 Phone: 606-324-1996 Fax: 606-833-2430 | |
Amr Idris, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 613 23rd St Ste 230, Ashland, KY 41101 Phone: 606-324-4745 Fax: 606-324-4941 | |
Paula K Larsen, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1000 Ashland Dr Ste G1, Ashland, KY 41101 Phone: 606-408-4900 Fax: 606-408-6643 | |
Michael Don Canty, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 617 23rd St, Suite 11, Ashland, KY 41101 Phone: 606-324-3188 Fax: 606-329-2237 | |
Dr. Ryann Acquino Pangan, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 613 23rd St Ste 130, Ashland, KY 41101 Phone: 606-329-9335 Fax: 606-324-6383 | |
Dr. Francisco Fernandez-gonzalez, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 613 23rd St Ste 310, Ashland, KY 41101 Phone: 606-833-2161 | |
Dr. Chad Jacob Tarabolous, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 617 23rd St, Suite 19, Ashland, KY 41101 Phone: 606-325-2221 Fax: 606-324-1326 |